The incidence of childhood celiac disease shows remarkable variations in different European countries, ranging from 1:300 live births in the western part of Ireland to 1:3500 in other countries (1, 2) . Variations within the same country have also been reported (3, 4) . Increases and decreases in the incidence of celiac disease have been described (4, 5) . Breast-feeding, the age of gluten introduction, and the amount of gluten intake, as well as the use of different diagnostic criteria may playa role in the varying incidence of celiac disease (6) . Recently, an increase in atypical clinical presentation of celiac disease, which may include recurrent abdominal pain, constipation, iron-resistent anemia, or short stature, has been described in children (7) and in adults (8, 9) . Differences in diagnostic awareness may result in incomparable data on incidence and prevalence (10) .
In The Netherlands, little is known about the incidence of childhood celiac disease. Based on the membership records of the Dutch Celiac Disease Society, a crude estimated prevalence of 12/100,000 inhabitants, both children and adults, was found in 1992 (11) . This is remarkably low compared with neighbor-ACT permitted examinationof their medical files was given by 97.3% of the parents of the celiac children. The mean crude incidence rate of diagnosed childhood celiac disease, calculated per 1000 live births per year, was 0.18. However, a significantincrease in reported incidence was demonstrated from 0.10 in 1976 to 0.32 in 1990.The best estimate,for the years 1985-1990, is 0.22/1000 live births, which is much lower than in most European countries. (Pediatr Res 37: 213-218, 1995) Abbreviations ESPGAN, European Society for Paediatric Gastroenterology and Nutrition ing countries. However, not all celiac patients are members of the Society. To investigate whether the prevalence and incidence of childhood celiac disease in The Netherlands are really that low, we started an extensive search, relying not only on the records of the Celiac Disease Society, but also on the files of pediatricians, the data of the Dutch National Medical Registration, and the Dutch Network and National Database of Pathology.
METHODS

Data collection.
Six Dutch provinces (Zuid-Holland, NoordHolland, Gelderland, Limburg, Utrecht, and Groningen), covering 47.9% of the Dutch surface area and 67.6% of the total Dutch population, were studied (Fig. 1) . This area comprises the four largest Dutch cities (Amsterdam, Rotterdam, The Hague, and Utrecht), all eight university hospitals in The Netherlands, and two agrarian districts and is representative of The Netherlands as a whole. Demographic and epidemiologic data of the general population were provided by the Dutch Central Bureau of Statistics (12) . The emigration and immigration rates in the 18-to 40-y-old patients remained stable: 2.7% in 1980 and 2.8% in 1989 for both. In the area, 1 917232 children were born between 1975 and 1991. The distribution of these births over the provinces also remained stable. Ninety-o St dv oreo eight percent of all children born in The Netherlands regularly visit Community Child Health Care Centres. In these centers, nurses and doctors check health and development and record weight and height on growth charts eight to 12 times during the first 4 y of life. All children attend 12 y of compulsory school free of charge, with at least two medical checkups (13) .
Between March 1991 and March 1993, all pediatricians working in the study area were asked by letter if they had any celiac patients under treatment. In the university hospitals, the pediatric gastroenterologists and the head of the outpatient clinic were addressed. The pediatricians who answered in the affirmative and those who did not respond were contacted by telephone.
Minimal inclusion criteria were as follows: 1) born in one of the six provinces studied; 2) diagnosis of celiac disease according to the revised ESPGAN criteria (14) based on at least one small-intestinal biopsy, showing (sub)total villous atrophy followed by a clinical or histologic response to a gluten-free diet (These diagnostic criteria are broader than the original ESPGAN criteria (15) , which required three small-intestinal biopsies. However, the data do permit the calculation of the incidence rate according to the stricter ESPGAN criteria.); 3) age at diagnosis (first small-intestinal biopsy) before age 15; and 4) celiac disease diagnosed from January 1975 to January 1991.
Additional sources of information were the anonymous membership records of the Dutch Celiac Disease Society, which has existed since 1974, and the data of the Dutch National Medical Registration, which has anonymously regis- GEORGE ET AL.
tered all diagnoses at discharge from hospital since 1975. If a possible celiac patient was found in a certain hospital through these sources, the pediatrician of the hospital was contacted again.
Informed consent was asked of the parents or patients to allow examination of the medical files, which were consulted for sex, date and place of birth, pattern of breast-feeding, age at gluten introduction, onset of symptoms, symptoms at presentation, age at diagnosis, number of small-intestinal biopsies, associated diseases, adherence to a gluten-free diet, and physical condition based on first and last measured height and weight.
Ascertainment. The data provided by the pediatricians, the Dutch Celiac Disease Society, and the Dutch National Medical Registration were cross-checked with the information of the Dutch Network and National Database of Pathology, which has registered the pathologic specimens taken in The Netherlands since 1975. Thus, if a patient was found via one of the three sources mentioned above, his or her records were checked in the Database of Pathology. However, if a possible celiac patient was found in this Database, but not via one of the three sources, we returned to the pediatrician to ask whether our finding was correct.
The study was approved by the Medical Ethical Committee of the University Hospital Leiden.
Data report and statistical analysis. The crude incidence rate of diagnosed childhood celiac disease was calculated using the number of children aged 0-14 y developing celiac disease in a given year as the numerator and the number of live births in that same year as the denominator, expressed per 1000. The 0-to 3-y age-specific cumulative incidence rate was calculated by using as the numerator the number of patients with celiac disease born in a defined year, whose celiac disease was diagnosed from their year of birth to the age of 3 y, and as the denominator the number of live births in that same year, expressed per 1000. Unless indicated otherwise, the prevalence rate of diagnosed childhood celiac disease was calculated using the number of children with celiac disease aged 0-14 y, at a certain date, as the numerator and the total number of children age 0-14 as denominator, expressed per 100000.
i' test for contingency tables, including comparison of figures obtained in different years in The Netherlands and in different European countries, and regression analysis were used; p < 0.05 was accepted as statistically significant. Where required, results were expressed as mean values ± SD. Binomial distribution was used to calculate the 95% confidence intervals for the age-specific cumulative incidence rates. In cidence rate. The mean crude incidence rate of diagnosed celiac disease was 0.18 per 1000 live births, with a minimum of 0.10 in 1976 and a maximum of 0.32 in 1990 (Fig. 2) . When only diagnoses according to the original ESPGAN criteria were included, the crude incidence rate over the whole period was 0.08. A significant increase in total incidence from 0.14 in
RESULTS
Response
found (p < 0.001). There were significant differences between the six provinces (p < 0.001). The highest total incidence rates in 1975-1990 were found in Limburg and Utrecht (0.25), the lowest in Zuid-Holland and Noord-Holland (0.14). Table 1 shows the crude incidence rates of celiac disease in some European countries (2) . There are significant differences be- Table 2 . From 1975-1979 to 1985-1987, an increase in incidence can be observed, which is not significant (p = 0.11).
Prevalence rate. The prevalence rate of diagnosed celiac disease per 100 000 inhabitants of all ages varied from 1.00 in 1980 to 2.76 in 1990 (Table 3) . Using the original ESPGAN criteria, the prevalence rates were 0.51 in 1980 and 1.24 in 1990. The prevalence rate per 100000 children aged 0-14 y was 4.7 in 1980 and 15.1 in 1990. For the children diagnosed according to the original ESPGAN criteria, the prevalence rates in the same years were 2.4 and 7.0, respectively. The lowest prevalence rate was found in Noord-Holland (11.6) and the highest in Utrecht (20.4). 74  76  78  80  82  84  86  88  90 Year of diagnosis Clinical picture. The clinical picture at presentation did not change significantly during the study period. The most common symptoms at presentation were abdominal distension (76.0%), chronic diarrhea (71.3%), and growth failure (63.2%). Figure 3 shows the new cases of celiac disease by age group and year of diagnosis. At the time of diagnosis, 58.8% of the celiac children were younger than 2 y old, and of these children, 48.2% were diagnosed according to the original ESPGAN criteria; 12.8% were older than 7 y. The mean age at diagnosis was 3.0 :±: 3.0 y. The time between onset of the symptoms and diagnosis was 15.6 :±: 23.6 rna (0.4 -163.4 rna).
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Of 225 celiac children, 8.9% had an associated disease such as selective IgA deficiency (5), diabetes mellitus type I (4), epidemiology of diagnosed celiac disease in Dutch children in six Dutch provinces (70% of the total population) with a stable emigration/immigration rate. We relied not only on the records of the Celiac Disease Society, but also on all pediatricians working in the area and on the data of the Dutch Medical Registration. The risk of incorrect diagnosis of celiac disease was minimized by including only those children with at least one intestinal biopsy that showed (sub)total villous atrophy, as ascertained by the Dutch Network and National Database of Pathology. Both the high response to our inquiry among the pediatricians (97.7%) and our final method of ascertainment give reliability to our findings.
In 48.2% of the children aged younger than 2 y at diagnosis of celiac disease, the strict original ESPGAN criteria were applied. Interestingly, 71.7% of the children in whom the disease was diagnosed before the age of 2 y and in whom the original ESPGAN criteria were not applied received their diagnosis after 1988. This can be explained in part by the short follow-up of this group, which has not yet reached the age necessary to undergo a gluten challenge. Another possibility is that the behavior of the pediatricians concerning the diagnosis of celiac disease has been relaxed during the last few years, partially because of an incorrect interpretation of the revised ESPGAN criteria for diagnosis (14) .
The mean crude incidence rate for diagnosed childhood celiac disease in 1975-1990 is 0.18/1000 live births, which is significantly lower than the incidence rates found in other European countries (Table 1) , although it is in line with recent data from Denmark (16) . A clear increase in reported incidence is found from 1976 (0.10) to 1990 (0.32). The best estimate of the present crude incidence is 0.22 for the period 1985-1990, because during this period more than 90% of all the pathologic specimens taken in The Netherlands were registered by the Dutch Network and National Database of Pathology, which makes the best possible ascertainment of the incidence. Even this crude incidence rate is low in comparison with that in other European countries. The 0-to 3-y age-specific cumulative incidence rate, chosen because most cases present at an early age, shows the same trend in increase as the crude incidence rate. This can be explained because the number of live births per year remained relatively stable in The Netherlands during the study period. However, the increase in age-specific cumulative incidence rate is not significant, possibly because only the data up to 1988 could be analyzed.
One possible explanation for the low incidence of celiac disease found in The Netherlands is underdiagnosis, caused by an increase in atypical presentation of celiac disease (7) . The majority of the celiac patients identified in our study presented themselves at a classic age (younger than 2 y) with a typical clinical picture of abdominal distension, chronic diarrhea, and growth failure. In Denmark, the only European country with a low incidence rate of identified childhood celiac disease comparable to the one found in The Netherlands (16) , an important increase of atypical clinical presentation has been reported. In Sweden, the European country with the highest incidence rate of childhood celiac disease, most of the children, like the Dutch children, present with the typical complaints of chronic diarrhea and malabsorption. However, whereas in Denmark the Down's syndrome (2), cystic fibrosis (2), alopecia (2), cow's milk protein allergy (2), epilepsy (1), juvenile rheumatoid arthritis (1), and chronic autoimmune hepatitis (1) . Of the children, 70.2 and 42.2% were below the 10th percentile for, respectively, weight and height at the moment of diagnosis. After being on a gluten-free diet for 0.7 to 17.5 Y (6.9 ± 4.7 SD), only 9.9% of the children were below the 10th percentile for weight and height. Eighty percent (80.3%) of all celiac patients were members of the Dutch Celiac Disease Society.
Numbers of small intestinal biopsies taken (according to the Dutch National Database of Pathology).
In 1985-1990, 2310 small intestinal biopsies were performed on children aged 0-14 y. Of these patients, 238 showed subtotal villous atrophy, which is a sign of celiac disease (ratio 1:10). Figure 4 shows a significant positive correlation between the yearly incidence of diagnosed childhood celiac disease and the number of biopsies per 1000 live births for the period [1985] [1986] [1987] [1988] [1989] [1990] (r = 0.87, p < 0.05). To find out whether, in the course of this period, a change in the frequency of subtotal villous atrophy occurred in relation to the total number of small intestinal biopsies, we calculated the yearly ratio and found no significant difference with a mean ratio of 1:9.7 ± 1.7 for every year.
Year of diagnosis
To investigate whether the incidence and prevalence of celiac disease in The Netherlands were really as low as had been reported (11), we started an extensive survey on the 3 
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Number of biopsies incidence of celiac disease has remained stable, the incidence rate in The Netherlands has increased significantly since 1975. Therefore, it seems reasonable to assume that the increase in incidence of celiac disease in The Netherlands largely depends on the increase of "classic" celiac disease. If this is the case, it does not seem likely that a changing clinical picture accounts for the low incidence of childhood celiac disease. However, the possibility that atypical forms of the disease are underdiagnosed in our country still remains. We are currently investigating this subject. Another possible explanation for the low incidence found could be a low frequency in the Dutch population of the genetic factors associated with celiac disease: HLA-DR3-DQ2 (17) . However, the frequencies of the associated HLA genes in The Netherlands (HLA-DR3: 0.13; HLA-DQ2:0.21; G. M. T. Schreuder, personal communication) are similar to or higher than those found in countries with a high incidence of celiac disease, such as Sweden (HLA-DR3: 0.15; HLA-DQ2: 0.13) (18) .
Environmental factors such as feeding practices could be the cause of the variations in incidence of celiac disease in different countries. For example, the high gluten content in the diet of 9-mo-old Swedish children (3573 mg of gluten per day) compared with the low gluten consumption by the Danish children at the same age (667 mg of gluten per day) has been implicated in the great difference in incidence and symptomatology between the two countries (6). The late and gradual introduction of gluten in the diet in The Netherlands, as recommended by the Community Child Health Care Centres since 1985 (19) , is very similar to the policy followed by the Danish National Bond of Health. However, the gluten consumption of the average Dutch child at the age of 9 mo is about 2000 mg of gluten per day (20) . This high gluten intake is largely due to the fact that the cereal consumption by the Dutch children at this age (43.6 g/d) mainly consists of wheat (69.9 mg of gluten per gram), whereas in Denmark the main type of cereal consumed (35.5 gld) is rye (5.8 mg of gluten per gram) (21) . However, the incidence of childhood celiac disease in Finland (1975 Finland ( -1989 ) is four times as high as in The Netherlands (2), but the amount of gluten intake at the age of 9 mo is half the amount that Dutch children ingest (6) . Thus, the extent to which the quantity of gluten intake really influences the incidence of celiac disease remains questionable. Breastfeeding is considered to be protective against celiac disease at the youngest age and might postpone signs and symptoms (22) . In The Netherlands, the percentage of children who are being breast-fed at the age of 3 mo has increased significantly since 1975 (p < 0.05) (13) . Among the celiac children, the same change in the pattern of breast-feeding has taken place (Table  4) . Nevertheless, it is in the youngest age group that the increase in diagnosis of celiac disease during the last years is most marked. 1975-1979 1980-1984 1985-1990 
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In The Netherlands, we have found a significant positive correlation between the yearly incidence of diagnosed childhood celiac disease and the number of small-intestinal biopsies taken. However, the ratio of biopsies with subtotal villous atrophy to the total number of biopsies remains stable (1:10 per year). To investigate whether a real increase in the incidence of celiac disease is occurring in The Netherlands, it is necessary to systematically screen (and take biopsies from) large parts of the population. However, our data suggest first that the more small-intestinal biopsies taken, the more celiac patients diagnosed, and second that the increase in diagnosed celiac disease does not result from a parallel increase of small-intestinal alterations, but from a higher awareness among pediatricians.
Celiac disease is a potentially premalignant disorder in adults (23) and children (24) . A life-long gluten-free diet seems to protect the celiac patient against the development of a malignancy (23) and should be advised in all cases. Whether the recent increase in diagnosis of celiac disease in The Netherlands is the result of a real increase in incidence or not, it results in more Dutch people who are at risk for this serious complication and who should consume a gluten-free diet.
In conclusion, even our highest estimate of the crude incidence rate of childhood celiac disease in The Netherlands, 0.22/1000 live births in [1985] [1986] [1987] [1988] [1989] [1990] , remains below the rates reported by all other European countries, excluding Denmark. Underdiagnosis, the amount of gluten intake at a young age, and breast-feeding do not seem to explain the low incidence in The Netherlands. A significant positive correlation was found between the number of small-intestinal biopsies taken and the number of identified cases of childhood celiac disease. A clear increase in incidence of childhood celiac disease from 1976 to 1990 was found, but it is uncertain whether the incidence will continue to increase. 
